Heterogeneity in nomenclature and abbreviation usage for anti-synthetase syndrome: a scoping review

Anushka Aggarwal(Indraprastha Apollo Hospitals), Rohit Aggarwal(University of Pittsburgh), Saloni Haldule(B. J. Medical College & Sassoon Hospital), Sara Faghihi‐Kashani(San Francisco VA Medical Center), Namratha Edpuganti(Mamata Medical College), Giovanni Zanframundo(University of Pavia), Simran Nirmal(B. J. Medical College & Sassoon Hospital), Parth Ladha(B. J. Medical College & Sassoon Hospital), Tanya Chandra(University of Pittsburgh), Nakul Jain(Netaji Subhas University of Technology), Lorenzo Cavagna(University of Pavia)
Rheumatology International
August 30, 2024
10.1007/s00296-024-05670-w
Cited by 1

Related Papers

Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
|Arthritis & Rheumatology|2024|162
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative
|Nature Reviews Rheumatology|2023|150
Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial
|Neurotherapeutics|2018|142
2023 American College of Rheumatology (<scp>ACR</scp>)/American College of Chest Physicians (<scp>CHEST</scp>) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
|Arthritis & Rheumatology|2024|122